Join
Live feed
·
PRReleasevia Quantisnow
Cortexyme Inc. logo

Cortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections

ByQuantisnow·Wall Street's wire, on your screen.
CRTX· Cortexyme Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRTX (Cortexyme Inc.) and more on Quantisnow.